Fundz

Who to call at miRecule, and when

Fundz watches for the moments miRecule starts buying, and tells you who to reach.

  • An alert the day miRecule raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at miRecule, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at miRecule. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

miRecule Partners with EMS Group Company Rio Biopharma to Enhance RNA Therapeutics Delivery.

Jul 31, 2026

Contract Type

partnership

GaithersburgBiotechnologyHealth CareGeneticsTherapeutics

Description

miRecule has announced a strategic collaboration with Rio Biofarma Brasil Ltda. to co-develop technologies improving RNA therapeutics delivery to various tissues. This partnership includes co-ownership of developed technologies and an equity investment from Rio Biofarma Brasil to support the collaboration.

Company Information

Company

miRecule

Location

Gaithersburg, Maryland, United States

About

miRecule, Inc. is a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases. The company aims to enable precise genetic-level interventions through innovative therapies. Their proprietary NAVIgGator™ platform supports the design of precision RNA medicines.

Predictive Intelligence
Strategic

ML-powered predictions for miRecule's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

miRecule signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.